Literature DB >> 19110194

Multifunctional drugs as neurotherapeutics.

Cornelis J Van der Schyf, Moussa B H Youdim.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19110194      PMCID： PMC5084251          DOI： 10.1016/j.nurt.2008.11.001

Source DB:  PubMed          Journal:  Neurotherapeutics        ISSN： 1878-7479            Impact factor:   7.620


× No keyword cloud information.
  6 in total

Review 1.  Peptide Pharmacological Approaches to Treating Traumatic Brain Injury: a Case for Arginine-Rich Peptides.

Authors:  Li Shan Chiu; Ryan S Anderton; Neville W Knuckey; Bruno P Meloni
Journal:  Mol Neurobiol       Date:  2016-11-14       Impact factor: 5.590

Review 2.  α2-Adrenoceptors are targets for antipsychotic drugs.

Authors:  Jan Brosda; Florian Jantschak; Heinz H Pertz
Journal:  Psychopharmacology (Berl)       Date:  2014-02-02       Impact factor: 4.530

3.  Bis(7)-tacrine protects retinal ganglion cells against excitotoxicity via NMDA receptor inhibition.

Authors:  Zu-Hai Zhang; Yu-Wei Liu; Fa-Gang Jiang; Xiang Tian; Yan-Hua Zhu; Jing-Bo Li; Qi Wang; Jia-Hua Fang
Journal:  Int J Ophthalmol       Date:  2011-04-18       Impact factor: 1.779

Review 4.  mGluR4-positive allosteric modulation as potential treatment for Parkinson's disease.

Authors:  Corey R Hopkins; Craig W Lindsley; Colleen M Niswender
Journal:  Future Med Chem       Date:  2009-06       Impact factor: 3.808

5.  Why do we need multifunctional neuroprotective and neurorestorative drugs for Parkinson's and Alzheimer's disorders?

Authors:  Moussa B H Youdim
Journal:  Rambam Maimonides Med J       Date:  2010-10-31

Review 6.  Rationale for the use of multifunctional drugs as neuroprotective agents for glaucoma.

Authors:  Jiahua Fang; Fagang Jiang; Jingbo Li; Yanhua Zhu
Journal:  Neural Regen Res       Date:  2012-02-05       Impact factor: 5.135
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.